The DOI matches its Crossref record; 92 of the 92 references it cites were found in a registry or an index.
Role of Smooth Muscle Cells in the Initiation and Early Progression of Atherosclerosis
Open accessAbstract
The initiation of atherosclerosis results from complex interactions of circulating factors and various cell types in the vessel wall, including endothelial cells, lymphocytes, monocytes, and smooth muscle cells (SMCs). Recent reviews highlight the role of activated endothelium and inflammatory cell recruitment in the initiation of and progression of early atherosclerosis. Yet, human autopsy studies, in vitro mechanistic studies, and in vivo correlative data suggest an important role for SMCs in the initiation of atherosclerosis. SMCs are the major producers of extracellular matrix within the vessel wall and in response to atherogenic stimuli can modify the type of matrix proteins produced. In turn, the type of matrix present can affect the lipid content of the developing plaque and the proliferative index of the cells that are adherent to it. SMCs are also capable of functions typically attributed to other cell types. Like macrophages, SMCs can express a variety of receptors for lipid uptake and can form foam-like cells, thereby participating in the early accumulation of plaque lipid. Like endothelial cells, SMCs can also express a variety of adhesion molecules such as vascular cell adhesion molecule-1 and intercellular adhesion molecule-1 to which monocytes and lymphocytes can adhere and migrate into the vessel wall. In addition, through these adhesion molecules, SMCs can also stabilize these cells against apoptosis, thus contributing to the early cellularity of the lesion. Like many cells within the developing plaque, SMCs also produce many cytokines such as PDGF, transforming growth factor-β, IFNγ, and MCP-1, all of which contribute to the initiation and propagation of the inflammatory response to lipid. Recent advances in SMC-specific gene modulation have enhanced our ability to determine the role of SMCs in early atherogenesis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Atherosclerosis--an inflammatory disease
Ross, R. (1999) · New England Journal of Medicine · doi:10.1056/nejm199901143400207 · Cited by 21,725
The pathogenesis of atherosclerosis: a perspective for the 1990s
Ross, R. (1993) · Nature · doi:10.1038/362801a0 · Cited by 10,630
Lusis, A. J. (2000) · Nature · doi:10.1038/35025203 · Cited by 4,839
Stary, H. C., Chandler, A. B., Dinsmore, R. E., Fuster, V., Glagov, S., Insull, W., Rosenfeld, M. E., Schwartz, C. J., Wagner, W. D., & Wissler, R. W. (1995) · Circulation · doi:10.1161/01.cir.92.5.1355 · Cited by 3,533
Molecular Regulation of Vascular Smooth Muscle Cell Differentiation in Development and Disease
Owens, G. K., Kumar, M. S., & Wamhoff, B. R. (2004) · Physiological Reviews · doi:10.1152/physrev.00041.2003 · Cited by 3,471
Pathogenesis of atherosclerosis
Falk, E. (2006) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2005.09.068 · Cited by 1,447
Faggiotto, A., Ross, R., & Harker, L. (1984) · Arteriosclerosis: An Official Journal of the American Heart Association, Inc. · doi:10.1161/01.atv.4.4.323 · Cited by 984
TGF-β stimulation and inhibition of cell proliferation: New mechanistic insights
Moses, H. L., Yang, E. Y., & Pietenpol, J. A. (1990) · Cell · doi:10.1016/0092-8674(90)90155-8 · Cited by 959
Evidence for a Monoclonal Origin of Human Atherosclerotic Plaques
Benditt, E. P., & Benditt, J. M. (1973) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.70.6.1753 · Cited by 910
IFN-gamma potentiates atherosclerosis in ApoE knock-out mice.
Gupta, S., Pablo, A. M., Jiang, X. C., Wang, N., Tall, A. R., & Schindler, C. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119465 · Cited by 868
Cited by
Smoking and Cardiovascular Disease: Mechanisms of Endothelial Dysfunction and Early Atherogenesis
Messner, B., & Bernhard, D. (2014) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.113.300156 · Cited by 1,139
Boettger, T., Beetz, N., Kostin, S., Schneider, J., Krüger, M., Hein, L., & Braun, T. (2009) · Journal of Clinical Investigation · doi:10.1172/jci38864 · Cited by 651
MicroRNA Regulation of Atherosclerosis
Feinberg, M. W., & Moore, K. J. (2016) · Circulation Research · doi:10.1161/circresaha.115.306300 · Cited by 627
Liu, X., Cheng, Y., Zhang, S., Lin, Y., Yang, J., & Zhang, C. (2009) · Circulation Research · doi:10.1161/circresaha.108.185363 · Cited by 553
Proinflammatory Phenotype of Perivascular Adipocytes: Influence of High-Fat Feeding
Chatterjee, T. K., Stoll, L. L., Denning, G. M., Harrelson, A., Blomkalns, A. L., Idelman, G., Rothenberg, F. G., Neltner, B., Romig-Martin, S. A., Dickson, E. W., et al. (2009) · Circulation Research · doi:10.1161/circresaha.108.182998 · Cited by 528
Molecular Biology of Atherosclerosis
Hopkins, P. N. (2013) · Physiological Reviews · doi:10.1152/physrev.00004.2012 · Cited by 459
Poldip2, a Novel Regulator of Nox4 and Cytoskeletal Integrity in Vascular Smooth Muscle Cells
Lyle, A. N., Deshpande, N. N., Taniyama, Y., Seidel-Rogol, B., Pounkova, L., Du, P., Papaharalambus, C., Lassègue, B., & Griendling, K. K. (2009) · Circulation Research · doi:10.1161/circresaha.109.193722 · Cited by 428
Atherosclerosis, platelets and thrombosis in acute ischaemic heart disease
Badimon, L., Padró, T., & Vilahur, G. (2012) · European Heart Journal: Acute Cardiovascular Care · doi:10.1177/2048872612441582 · Cited by 430
Therapeutic strategies targeting inflammation and immunity in atherosclerosis: how to proceed?
Engelen, S. E., Robinson, A. J. B., Zurke, Y.-X., & Monaco, C. (2022) · Nature Reviews Cardiology · doi:10.1038/s41569-021-00668-4 · Cited by 425
Smooth muscle cell-driven vascular diseases and molecular mechanisms of VSMC plasticity
Frismantiene, A., Philippova, M., Erne, P., & Resink, T. J. (2018) · Cellular Signalling · doi:10.1016/j.cellsig.2018.08.019 · Cited by 406
Microparticles, Vascular Function, and Atherothrombosis
Rautou, P.-E., Vion, A.-C., Amabile, N., Chironi, G., Simon, A., Tedgui, A., & Boulanger, C. M. (2011) · Circulation Research · doi:10.1161/circresaha.110.233163 · Cited by 376
Li, Y., Reddy, M. A., Miao, F., Shanmugam, N., Yee, J.-K., Hawkins, D., Ren, B., & Natarajan, R. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m802800200 · Cited by 353
Organs-on-chips: breaking the in vitro impasse
Meer, A. D. V. D., & Berg, A. V. D. (2012) · Integrative Biology · doi:10.1039/c2ib00176d · Cited by 314
Wang, Y., Zhao, X., Jin, H., Wei, H., Li, W., Bu, D., Tang, X., Ren, Y., Tang, C., & Du, J. (2009) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.108.179333 · Cited by 307
Ten-Eleven Translocation-2 (TET2) Is a Master Regulator of Smooth Muscle Cell Plasticity
Liu, R., Jin, Y., Tang, W. H., Qin, L., Zhang, X., Tellides, G., Hwa, J., Yu, J., & Martin, K. A. (2013) · Circulation · doi:10.1161/circulationaha.113.002887 · Cited by 294
MicroRNA-145 Targeted Therapy Reduces Atherosclerosis
Lovren, F., Pan, Y., Quan, A., Singh, K. K., Shukla, P. C., Gupta, N., Steer, B. M., Ingram, A. J., Gupta, M., Al-Omran, M., et al. (2012) · Circulation · doi:10.1161/circulationaha.111.084186 · Cited by 281
MicroRNA‐26a is a novel regulator of vascular smooth muscle cell function
Leeper, N. J., Raiesdana, A., Kojima, Y., Chun, H. J., Azuma, J., Maegdefessel, L., Kundu, R. K., Quertermous, T., Tsao, P. S., & Spin, J. M. (2011) · Journal of Cellular Physiology · doi:10.1002/jcp.22422 · Cited by 280
Physiological Diagnostic Criteria for Vascular Failure
Tanaka, A., Tomiyama, H., Maruhashi, T., Matsuzawa, Y., Miyoshi, T., Kabutoya, T., Kario, K., Sugiyama, S., Munakata, M., Ito, H., et al. (2018) · Hypertension · doi:10.1161/hypertensionaha.118.11554 · Cited by 280
Role of Vitamin D in Atherosclerosis
Kassi, E., Adamopoulos, C., Basdra, E. K., & Papavassiliou, A. G. (2013) · Circulation · doi:10.1161/circulationaha.113.002654 · Cited by 279
Complex Regulation and Function of the Inflammatory Smooth Muscle Cell Phenotype in Atherosclerosis
Orr, A. W., Hastings, N. E., Blackman, B. R., & Wamhoff, B. R. (2010) · Journal of Vascular Research · doi:10.1159/000250095 · Cited by 275
Zhou, J., Li, Y.-S., Nguyen, P., Wang, K.-C., Weiss, A., Kuo, Y.-C., Chiu, J.-J., Shyy, J. Y., & Chien, S. (2013) · Circulation Research · doi:10.1161/circresaha.113.280883 · Cited by 255
Villeneuve, L. M., Kato, M., Reddy, M. A., Wang, M., Lanting, L., & Natarajan, R. (2010) · Diabetes · doi:10.2337/db10-0208 · Cited by 186
Zhou, A. X., & Tabas, I. (2013) · Seminars in Immunopathology · doi:10.1007/s00281-013-0372-x · Cited by 121
Jojima, T., Uchida, K., Akimoto, K., Tomotsune, T., Yanagi, K., Iijima, T., Suzuki, K., Kasai, K., & Aso, Y. (2017) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2017.04.001 · Cited by 105
Khodabandehlou, K., Masehi-Lano, J. J., Poon, C., Wang, J., & Chung, E. J. (2017) · Experimental Biology and Medicine · doi:10.1177/1535370217693116 · Cited by 91
Shi, L., Ji, Y., Jiang, X., Zhou, L., Xu, Y., Li, Y., Jiang, W., Meng, P., & Liu, X. (2015) · Cardiovascular Diabetology · doi:10.1186/s12933-015-0177-4 · Cited by 91
Alloza, I., Goikuria, H., Idro, J. L., Triviño, J. C., Fernández Velasco, J. M., Elizagaray, E., García-Barcina, M., Montoya-Murillo, G., Sarasola, E., Vega Manrique, R., et al. (2017) · Scientific Reports · doi:10.1038/s41598-017-03687-9 · Cited by 25
Wu, L.-P., Gong, Z.-F., Wang, H., Zhou, Z.-S., Zhang, M.-M., Liu, C., Ren, H.-M., Yang, J., Han, Y., & Zeng, C.-Y. (2020) · Acta Pharmacologica Sinica · doi:10.1038/s41401-019-0293-x · Cited by 12
Engineering the cardiac tissue microenvironment
Ronan, G., Bahcecioglu, G., Aliyev, N., & Zorlutuna, P. (2024) · Progress in Biomedical Engineering · doi:10.1088/2516-1091/ad0ea7 · Cited by 4
Metadata
- Authors
- Doran, A. C., Meller, N., & McNamara, C. A.
- Venue
- Arteriosclerosis, Thrombosis, and Vascular Biology
- Published
- 2008-05
- Volume
- 28
- Issue
- 5
- Pages
- 812-819
- ISSN
- 1079-5642 (ISSN-L)
- 1524-4636
- OpenAlex
- W2146917818
- Cited by
- 804
- References
- 92
- FWCI
- 17.32
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.